Keywords: Pfizer, Rewvatio, PAU, USA, FDA, Use in children

FDA warns against use of Pfizer's Revatio in children with PAH

Article | 02 September 2012

Print This

The US Food and Drug Administration is recommending that Revatio (sildenafil), marketed by US drugs behemoth Pfizer (NYSE: PFE) should ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in